Cash flow Moderna, Inc.

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-24 pm EST			5-day change	1st Jan Change
41.41 ^USD	-2.31%		+21.58%	-0.41%

Jan. 24	Health Care Up on Novo Nordisk Optimism -- Health Care Roundup	DJ
Jan. 24	S&P 500 Posts Weekly Gain Amid Earnings Beats, Start of Trump Presidency	MT

8405dfaf7d.yX72m5ulY5kdDO8vtIyupp0rX5l5hfPQdC9zJZyaJgM.8Sucq_DgPP1IP9tg7sHKnrAGEaEWz7-3Ll8WdszZbEr7PLL68NRRwUJEiA

Published financial data: MODERNA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	60.21M	803M	18.47B	19.26B	6.67B
Other Revenues, Total	-	-	-	-	177M
Total Revenues	60.21M	803M	18.47B	19.26B	6.85B
Cost of Goods Sold, Total	496M	1.38B	4.61B	8.71B	9.54B
Gross Profit	-436M	-575M	13.86B	10.55B	-2.69B
Selling General & Admin Expenses, Total	110M	188M	567M	1.13B	1.55B
Other Operating Expenses, Total	110M	188M	567M	1.13B	1.55B
Operating Income	-546M	-763M	13.3B	9.42B	-4.24B
Interest Expense, Total	-6.61M	-9.89M	-18M	-29M	-38M
Interest And Investment Income	38.53M	24.72M	18M	200M	421M
Net Interest Expenses	31.92M	14.83M	0	171M	383M
Currency Exchange Gains (Loss)	-	-	-8M	48M	-
Other Non Operating Income (Expenses)	-921K	2.74M	-4M	-44M	-14M
EBT, Excl. Unusual Items	-515M	-746M	13.28B	9.6B	-3.87B
Gain (Loss) On Sale Of Investments	323K	1.3M	1M	-20M	-72M
Gain (Loss) On Sale Of Assets	-316K	-238K	-	-	-
EBT, Incl. Unusual Items	-515M	-745M	13.28B	9.58B	-3.94B
Income Tax Expense	-695K	2.55M	1.08B	1.21B	772M
Earnings From Continuing Operations	-514M	-747M	12.2B	8.36B	-4.71B
Net Income to Company	-514M	-747M	12.2B	8.36B	-4.71B
Net Income - (IS)	-514M	-747M	12.2B	8.36B	-4.71B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-514M	-747M	12.2B	8.36B	-4.71B
Net Income to Common Excl. Extra Items	-514M	-747M	12.2B	8.36B	-4.71B
Per Share Items
Net EPS - Basic	-1.55	-1.96	30.28	21.22	-12.34
Basic EPS - Continuing Operations	-1.55	-1.96	30.28	21.22	-12.34
Basic Weighted Average Shares Outstanding	331M	381M	403M	394M	382M
Net EPS - Diluted	-1.55	-1.96	28.29	20.12	-12.34
Diluted EPS - Continuing Operations	-1.55	-1.96	28.29	20.12	-12.34
Diluted Weighted Average Shares Outstanding	331M	381M	431M	416M	382M
Normalized Basic EPS	-0.97	-1.22	20.6	15.22	-6.33
Normalized Diluted EPS	-0.97	-1.22	19.26	14.42	-6.33
Payout Ratio	-	-	-	-	-
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	-515M	-732M	13.53B	9.77B	-3.62B
EBITA	-546M	-763M	13.3B	9.42B	-4.24B
EBIT	-546M	-763M	13.3B	9.42B	-4.24B
EBITDAR	-493M	-696M	13.7B	9.98B	-3.42B
Total Revenues (As Reported)	60.21M	803M	18.47B	19.26B	6.85B
Effective Tax Rate - (Ratio)	0.14	-0.34	8.15	12.67	-19.58
Current Domestic Taxes	505K	32K	1.34B	1.73B	-153M
Current Foreign Taxes	-	2.52M	40M	57M	24M
Total Current Taxes	505K	2.55M	1.38B	1.79B	-129M
Deferred Domestic Taxes	-1.2M	-	-294M	-576M	896M
Deferred Foreign Taxes	-	-	-2M	-2M	5M
Total Deferred Taxes	-1.2M	-	-296M	-578M	901M
Normalized Net Income	-322M	-466M	8.3B	6B	-2.42B
Interest on Long-Term Debt	6.56M	9.89M	17M	29M	38M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	204M
Selling and Marketing Expenses	-	-	-	-	204M
General and Administrative Expenses	110M	-	-	-	-
Research And Development Expense From Footnotes	496M	1.37B	1.99B	3.3B	4.84B
Net Rental Expense, Total	21.41M	35.49M	173M	213M	203M
Imputed Operating Lease Interest Expense	13.37M	15.03M	43.21M	46.71M	50.52M
Imputed Operating Lease Depreciation	8.04M	20.46M	130M	166M	152M
Stock-Based Comp., COGS (Total)	48.26M	56.16M	90M	138M	194M
Stock-Based Comp., G&A Exp. (Total)	32.86M	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	36.87M	52M	88M	111M
Total Stock-Based Compensation	81.12M	93.02M	142M	226M	305M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	236M	2.62B	6.85B	3.2B	2.91B
Short Term Investments	867M	1.98B	3.88B	6.7B	5.7B
Total Cash And Short Term Investments	1.1B	4.61B	10.73B	9.9B	8.6B
Accounts Receivable, Total	5.37M	1.39B	3.18B	1.38B	892M
Other Receivables	10.93M	19.97M	121M	243M	189M
Notes Receivable	-	-	-	36M	-
Total Receivables	16.3M	1.41B	3.3B	1.66B	1.08B
Inventory	-	46.53M	1.44B	1.17B	270M
Prepaid Expenses	8.48M	15.65M	126M	216M	266M
Restricted Cash	1.03M	1.03M	-	-	-
Other Current Assets, Total	-	217M	481M	481M	104M
Total Current Assets	1.13B	6.3B	16.07B	13.43B	10.32B
Gross Property Plant And Equipment	382M	507M	1.74B	2.8B	3.09B
Accumulated Depreciation	-94.58M	-120M	-352M	-658M	-433M
Net Property Plant And Equipment	288M	387M	1.38B	2.14B	2.66B
Long-term Investments	160M	639M	6.84B	8.36B	4.74B
Goodwill	-	-	-	-	52M
Other Intangibles, Total	-	-	-	-	44M
Deferred Tax Assets Long-Term	-	-	326M	982M	81M
Other Long-Term Assets, Total	12.72M	12.93M	46M	946M	523M
Total Assets	1.59B	7.34B	24.67B	25.86B	18.43B
Liabilities
Accounts Payable, Total	7.09M	18.36M	302M	487M	520M
Accrued Expenses, Total	63.62M	452M	1.47B	1.83B	1.07B
Current Portion of Leases	3.58M	30.3M	211M	196M	25M
Current Income Taxes Payable	-	-	876M	48M	63M
Unearned Revenue Current, Total	63.31M	3.87B	6.25B	2.04B	568M
Other Current Liabilities	5.51M	20.94M	14M	321M	770M
Total Current Liabilities	143M	4.39B	9.13B	4.92B	3.02B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	132M	207M	705M	1B	1.22B
Unearned Revenue Non Current	139M	177M	615M	673M	83M
Other Non Current Liabilities	138K	1.85M	76M	135M	256M
Total Liabilities	415M	4.78B	10.52B	6.74B	4.57B
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	34K	40K	-	-	-
Additional Paid In Capital	2.67B	4.8B	4.21B	1.17B	371M
Retained Earnings	-1.5B	-2.24B	9.96B	18.32B	13.61B
Comprehensive Income and Other	1.8M	3M	-24M	-370M	-123M
Total Common Equity	1.17B	2.56B	14.14B	19.12B	13.85B
Total Equity	1.17B	2.56B	14.14B	19.12B	13.85B
Total Liabilities And Equity	1.59B	7.34B	24.67B	25.86B	18.43B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	369M	400M	403M	386M	382M
ECS Total Common Shares Outstanding	337M	399M	403M	385M	382M
Book Value / Share	3.49	6.42	35.1	49.67	36.27
Tangible Book Value	1.17B	2.56B	14.14B	19.12B	13.76B
Tangible Book Value Per Share	3.49	6.42	35.1	49.67	36.02
Total Debt	136M	238M	916M	1.2B	1.24B
Net Debt	-967M	-4.37B	-16.65B	-17.02B	-12.04B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	9M	8M	-
Debt Equivalent Oper. Leases	171M	284M	1.38B	1.7B	1.62B
Account Code - Inventory Valuation	3	5	5	5	5
Inventories - Raw Materials, Total	-	36.22M	870M	575M	163M
Inventories - Work In Process, Total	-	9.02M	338M	205M	15M
Inventories - Finished Goods, Total	-	1.29M	233M	169M	24M
Land - (BS)	-	-	-	11M	22M
Buildings, Total	-	-	-	-	-
Machinery, Total	124M	139M	202M	343M	445M
Full Time Employees	830	1.3K	2.7K	3.9K	5.6K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-514M	-747M	12.2B	8.36B	-4.71B
Depreciation & Amortization - CF	31.02M	93.54M	232M	348M	621M
Depreciation & Amortization, Total	31.02M	93.54M	232M	348M	621M
(Gain) Loss From Sale Of Asset	316K	238K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-3.74M	10.18M	54M	31M	-26M
Stock-Based Compensation (CF)	81.12M	93.02M	142M	226M	305M
Other Operating Activities, Total	-	-	-318M	-531M	835M
Change In Accounts Receivable	7.22M	-1.39B	-1.78B	1.79B	493M
Change In Inventories	-	-46.53M	-1.39B	492M	747M
Change In Accounts Payable	-23.96M	11.88M	204M	240M	13M
Change in Unearned Revenues	-44.12M	3.84B	2.82B	-4.16B	-2.06B
Change In Income Taxes	-	-	876M	-828M	15M
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	7.2M	155M	582M	-992M	653M
Cash from Operations	-459M	2.03B	13.62B	4.98B	-3.12B
Capital Expenditure	-31.55M	-67.45M	-284M	-400M	-707M
Cash Acquisitions	-	-	-	-	-85M
Investment in Marketable and Equity Securities, Total	16.61M	-1.6B	-8.24B	-4.74B	5.02B
Other Investing Activities, Total	-	-	-	-40M	-23M
Cash from Investing	-14.94M	-1.67B	-8.52B	-5.18B	4.21B
Long-Term Debt Issued, Total	971K	-	-	-	-
Total Debt Issued	971K	-	-	-	-
Long-Term Debt Repaid, Total	-	-6.22M	-140M	-184M	-270M
Total Debt Repaid	-	-6.22M	-140M	-184M	-270M
Issuance of Common Stock	50.15M	2.04B	124M	65M	46M
Repurchase of Common Stock	-	-	-857M	-3.33B	-1.15B
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Cash from Financing	51.12M	2.03B	-873M	-3.45B	-1.38B
Net Change in Cash	-423M	2.39B	4.22B	-3.64B	-289M
Supplemental Items
Cash Interest Paid	-	8.53M	14M	25M	39M
Cash Income Tax Paid (Refund)	416K	572K	480M	2.73B	-357M
Levered Free Cash Flow	-332M	2.19B	9.29B	3.67B	-2.38B
Unlevered Free Cash Flow	-328M	2.2B	9.3B	3.69B	-2.36B
Change In Net Working Capital	67.5M	-2.55B	-904M	2.38B	-71M
Net Debt Issued / Repaid	971K	-6.22M	-140M	-184M	-270M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-19.21	-10.69	51.93	23.3	-11.97
Return on Total Capital	-23.73	-23.21	93.06	33.28	-14.96
Return On Equity %	-38	-39.99	146.08	50.27	-28.59
Return on Common Equity	-38	-39.99	146.08	50.27	-28.59
Margin Analysis
Gross Profit Margin %	-724.31	-71.56	75.05	54.78	-39.28
SG&A Margin	182.07	23.43	3.07	5.88	22.62
EBITDA Margin %	-854.85	-91.1	73.24	50.71	-52.83
EBITA Margin %	-906.38	-94.99	71.98	48.9	-61.9
EBIT Margin %	-906.38	-94.99	71.98	48.9	-61.9
Income From Continuing Operations Margin %	-853.73	-92.99	66.06	43.41	-68.84
Net Income Margin %	-853.73	-92.99	66.06	43.41	-68.84
Net Avail. For Common Margin %	-853.73	-92.99	66.06	43.41	-68.84
Normalized Net Income Margin	-534.31	-58	44.95	31.13	-35.32
Levered Free Cash Flow Margin	-551.6	272.65	50.31	19.04	-34.8
Unlevered Free Cash Flow Margin	-544.74	273.42	50.37	19.14	-34.45
Asset Turnover
Asset Turnover	0.03	0.18	1.15	0.76	0.31
Fixed Assets Turnover	0.24	2.38	20.87	10.94	2.86
Receivables Turnover (Average Receivables)	6.71	1.15	8.09	8.45	5.86
Inventory Turnover (Average Inventory)	-	-	6.19	6.02	13.27
Short Term Liquidity
Current Ratio	7.89	1.43	1.76	2.73	3.42
Quick Ratio	7.82	1.37	1.54	2.34	3.21
Operating Cash Flow to Current Liabilities	-3.21	0.46	1.49	1.01	-1.03
Days Sales Outstanding (Average Receivables)	54.42	317.97	45.11	43.2	62.29
Days Outstanding Inventory (Average Inventory)	-	-	58.93	60.67	27.51
Average Days Payable Outstanding	14.08	-	9.73	17.67	21.27
Cash Conversion Cycle (Average Days)	-	-	94.32	86.21	68.54
Long Term Solvency
Total Debt/Equity	11.57	9.28	6.48	6.28	8.97
Total Debt / Total Capital	10.37	8.49	6.08	5.9	8.23
LT Debt/Equity	11.27	8.09	4.98	5.25	8.79
Long-Term Debt / Total Capital	10.1	7.41	4.68	4.94	8.07
Total Liabilities / Total Assets	26.09	65.09	42.66	26.05	24.81
EBIT / Interest Expense	-82.53	-77.19	738.67	324.83	-111.55
EBITDA / Interest Expense	-74.6	-70.44	761.17	344.17	-89.87
(EBITDA - Capex) / Interest Expense	-79.38	-77.27	745.39	330.38	-108.47
Total Debt / EBITDA	-0.28	-0.34	0.07	0.12	-0.36
Net Debt / EBITDA	1.96	6.28	-1.22	-1.71	3.53
Total Debt / (EBITDA - Capex)	-0.26	-0.31	0.07	0.13	-0.3
Net Debt / (EBITDA - Capex)	1.84	5.72	-1.24	-1.78	2.92
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-55.42	1.23K	2.2K	4.29	-64.45
Gross Profit, 1 Yr. Growth %	36.7	31.82	-2.51K	-23.88	-125.49
EBITDA, 1 Yr. Growth %	32.52	42.2	-1.95K	-27.79	-137.04
EBITA, 1 Yr. Growth %	32.05	39.84	-1.84K	-29.15	-145
EBIT, 1 Yr. Growth %	32.05	39.84	-1.84K	-29.15	-145
Earnings From Cont. Operations, 1 Yr. Growth %	33.6	45.34	-1.73K	-31.47	-156.37
Net Income, 1 Yr. Growth %	33.6	45.34	-1.73K	-31.47	-156.37
Normalized Net Income, 1 Yr. Growth %	31.8	44.85	-1.88K	-27.77	-140.33
Diluted EPS Before Extra, 1 Yr. Growth %	-68.64	26.08	-1.54K	-28.88	-161.33
Accounts Receivable, 1 Yr. Growth %	-57.34	25.8K	128.25	-56.38	-35.6
Inventory, 1 Yr. Growth %	-	-	2.97K	-32.41	-76.88
Net Property, Plant and Equip., 1 Yr. Growth %	35.82	34.45	257.36	54.66	24.26
Total Assets, 1 Yr. Growth %	-19	361.6	236.23	4.82	-28.74
Tangible Book Value, 1 Yr. Growth %	-23.23	118.02	452.32	35.19	-28.06
Common Equity, 1 Yr. Growth %	-23.23	118.02	452.32	35.19	-27.55
Cash From Operations, 1 Yr. Growth %	38.72	-541.64	571.93	-63.43	-162.6
Capital Expenditures, 1 Yr. Growth %	-70.17	113.75	317.65	40.84	76.75
Levered Free Cash Flow, 1 Yr. Growth %	32	-759.55	324.3	-60.53